Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Gap junction (mmu04540)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adrb1
KLA  ATP  ATP+KLA
 NM_007419 adrenergic receptor, beta 1 (Adrb1), mRNA [NM_007419] KLA .88 .86 .88 .86 .87 .87 .87
ATP .97 .97 .95 .89 .89 .90 .87
KLA/ATP .90 .88 .91 .84 .91 .79 .82
Cdc2a
KLA  ATP  ATP+KLA
 NM_007659 cell division cycle 2 homolog A (S. pombe) (Cdc2a), mRNA [NM_007659] KLA .72 .68 .65 .58 .58 .59 .48
ATP 1.01 1.05 1.21 1.06 .83 .77 .51
KLA/ATP .68 .63 .79 .70 .59 .59 .51
Csnk1d
KLA  ATP  ATP+KLA
 NM_027874 casein kinase 1, delta (Csnk1d), transcript variant 2, mRNA [NM_027874] KLA 1.18 1.24 1.40 1.51 1.46 1.33 1.20
ATP 1.03 .98 .90 .97 1.70 1.81 1.18
KLA/ATP 1.30 1.36 1.20 1.37 1.98 2.29 1.67
Csnk1d
KLA  ATP  ATP+KLA
 NM_139059 casein kinase 1, delta (Csnk1d), transcript variant 1, mRNA [NM_139059] KLA 1.72 1.90 2.07 2.00 2.02 1.88 1.60
ATP .94 1.05 1.01 1.34 2.03 2.97 1.70
KLA/ATP 1.77 1.86 1.85 2.18 2.27 2.99 3.01
Drd1a
KLA  ATP  ATP+KLA
 NM_010076 dopamine receptor D1A (Drd1a), mRNA [NM_010076] KLA .94 .99 1.02 .98 .98 .99 1.06
ATP 1.07 1.03 1.01 1.08 1.08 .96 1.04
KLA/ATP 1.04 1.00 1.01 1.06 1.08 1.06 1.09
Drd2
KLA  ATP  ATP+KLA
 NM_010077 dopamine receptor 2 (Drd2), mRNA [NM_010077] KLA 1.02 .98 1.03 1.09 1.07 .97 1.09
ATP 1.07 1.00 .98 1.11 1.03 1.01 1.03
KLA/ATP 1.13 1.12 1.09 1.08 1.02 1.01 1.11
Drd2
KLA  ATP  ATP+KLA
 X55674 gb|M.musculus mRNA for D2A dopamine receptor [X55674] KLA .95 1.00 1.06 .98 .97 1.02 1.02
ATP .97 .97 .99 .97 .99 .97 1.01
KLA/ATP .97 1.03 .91 .90 .95 .89 1.00
Egf
KLA  ATP  ATP+KLA
 NM_010113 epidermal growth factor (Egf), mRNA [NM_010113] KLA .89 .90 .81 .83 .83 .86 .92
ATP 1.03 1.03 .95 .84 .67 .79 .88
KLA/ATP .86 .86 .77 .77 .69 .78 .83
Egfr
KLA  ATP  ATP+KLA
 NM_007912 epidermal growth factor receptor (Egfr), transcript variant 2, mRNA [NM_007912] KLA 1.10 1.07 1.14 1.11 1.08 1.03 .90
ATP .99 1.00 1.04 .98 .97 1.15 1.14
KLA/ATP 1.07 1.10 1.16 1.08 1.01 .97 .94
Egfr
KLA  ATP  ATP+KLA
 NM_207655 epidermal growth factor receptor (Egfr), transcript variant 1, mRNA [NM_207655] KLA 1.57 1.44 1.47 1.31 .96 .92 .76
ATP .97 .93 1.10 1.00 1.41 2.97 .86
KLA/ATP 1.44 1.50 1.61 1.30 1.14 1.21 .82
Gja1
KLA  ATP  ATP+KLA
 NM_010288 gap junction protein, alpha 1 (Gja1), mRNA [NM_010288] KLA 3.34 3.26 3.59 3.08 2.26 1.50 .90
ATP 1.01 1.08 1.38 1.42 3.24 16.32 1.56
KLA/ATP 3.47 3.78 3.71 3.44 2.75 4.11 1.77
Gjd2
KLA  ATP  ATP+KLA
 NM_010290 gap junction protein, delta 2 (Gjd2), mRNA [NM_010290] KLA .96 1.00 1.03 .96 .96 .96 .96
ATP 1.02 1.02 1.01 .96 1.00 .98 .92
KLA/ATP .93 1.06 .95 .98 .97 .99 1.03
Gna11
KLA  ATP  ATP+KLA
 NM_010301 guanine nucleotide binding protein, alpha 11 (Gna11), mRNA [NM_010301] KLA .62 .65 .69 .79 .94 1.00 .96
ATP 1.00 .94 .63 .53 .79 1.13 1.22
KLA/ATP .64 .60 .56 .55 .81 1.16 1.18
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Grm1
KLA  ATP  ATP+KLA
 NM_016976 glutamate receptor, metabotropic 1 (Grm1), transcript variant 1, mRNA [NM_016976] KLA 1.16 1.07 1.10 1.18 1.08 1.04 1.15
ATP 1.06 1.05 1.02 .99 1.00 1.09 1.02
KLA/ATP 1.04 1.12 1.06 1.11 1.10 1.32 1.35
Grm5
KLA  ATP  ATP+KLA
 NM_001081414 glutamate receptor, metabotropic 5 (Grm5), mRNA [NM_001081414] KLA 1.04 1.05 1.04 1.04 1.02 1.01 1.05
ATP .99 1.02 1.03 1.01 .99 1.00 1.03
KLA/ATP 1.03 1.02 1.02 1.03 1.01 1.01 1.05
Gucy1a3
KLA  ATP  ATP+KLA
 NM_021896 guanylate cyclase 1, soluble, alpha 3 (Gucy1a3), mRNA [NM_021896] KLA 1.01 1.01 1.04 .99 .99 .97 .99
ATP .99 1.01 .99 .99 .97 1.02 1.02
KLA/ATP 1.00 .96 1.00 .99 .98 1.04 .99
Gucy1b2
KLA  ATP  ATP+KLA
 NM_172810 guanylate cyclase 1, soluble, beta 2 (Gucy1b2), mRNA [NM_172810] KLA 1.02 1.03 1.03 1.09 .95 1.06 .91
ATP 1.01 1.03 1.01 1.08 .96 1.04 .90
KLA/ATP 1.04 1.03 .99 1.05 .97 .96 .84
Gucy1b3
KLA  ATP  ATP+KLA
 NM_017469 guanylate cyclase 1, soluble, beta 3 (Gucy1b3), mRNA [NM_017469] KLA .99 .99 .99 1.01 .98 .98 1.00
ATP .98 .98 .98 .98 .98 1.00 1.01
KLA/ATP .96 .99 .98 1.01 .99 .99 .99
Hras1
KLA  ATP  ATP+KLA
 NM_008284 Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] KLA .79 .82 .77 .82 .94 1.03 1.07
ATP 1.01 .95 .69 .83 .79 1.12 1.15
KLA/ATP .84 .77 .61 .65 .82 1.00 1.05
Htr2a
KLA  ATP  ATP+KLA
 NM_172812 5-hydroxytryptamine (serotonin) receptor 2A (Htr2a), mRNA [NM_172812] KLA 1.00 1.01 1.03 1.00 .97 .96 .99
ATP .97 .97 .95 1.12 1.41 .98 .95
KLA/ATP .92 1.01 1.07 1.08 1.03 .98 1.06
Htr2b
KLA  ATP  ATP+KLA
 NM_008311 5-hydroxytryptamine (serotonin) receptor 2B (Htr2b), mRNA [NM_008311] KLA .47 .44 .41 .46 .73 1.91 1.14
ATP .90 .92 .95 1.02 1.24 1.47 11.87
KLA/ATP .44 .43 .51 .56 1.05 4.41 10.84
Htr2c
KLA  ATP  ATP+KLA
 AK086348 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930023E13 product:5-hydroxytryptamine (serotonin) receptor 2C, full insert sequence. [AK086348] KLA 1.01 1.01 1.00 1.03 1.03 1.04 1.04
ATP 1.01 1.00 1.00 1.04 1.02 1.03 .99
KLA/ATP .99 1.02 .96 1.07 1.03 1.06 1.06
Htr2c
KLA  ATP  ATP+KLA
 NM_008312 5-hydroxytryptamine (serotonin) receptor 2C (Htr2c), mRNA [NM_008312] KLA 1.03 1.08 1.00 1.05 1.02 1.02 .98
ATP .96 1.02 1.01 1.05 .98 .99 1.03
KLA/ATP 1.00 1.00 1.04 .97 .96 .96 .98
Itpr1
KLA  ATP  ATP+KLA
 NM_010585 inositol 1,4,5-triphosphate receptor 1 (Itpr1), mRNA [NM_010585] KLA 3.66 3.69 6.74 8.11 7.08 4.40 1.22
ATP 1.08 .95 1.19 .94 1.09 1.00 .68
KLA/ATP 3.48 3.58 5.86 6.03 4.01 2.31 .97
Itpr2
KLA  ATP  ATP+KLA
 NM_019923 inositol 1,4,5-triphosphate receptor 2 (Itpr2), transcript variant 1, mRNA [NM_019923] KLA 1.41 1.38 1.43 1.42 1.30 1.07 1.01
ATP 1.00 1.00 .97 .97 1.07 1.15 1.06
KLA/ATP 1.39 1.48 1.64 1.42 1.07 .83 .95
Itpr3
KLA  ATP  ATP+KLA
 NM_080553 inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] KLA .55 .51 .45 .41 .34 .34 .45
ATP 1.01 .92 1.02 .57 .46 .34 1.22
KLA/ATP .56 .48 .48 .29 .33 .27 .65
Kras
KLA  ATP  ATP+KLA
 NM_021284 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] KLA .53 .49 .40 .42 .49 .95 1.05
ATP .98 1.01 1.16 1.17 1.39 1.29 1.74
KLA/ATP .50 .47 .50 .56 1.00 1.24 1.58
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Map2k2
KLA  ATP  ATP+KLA
 NM_023138 mitogen-activated protein kinase kinase 2 (Map2k2), mRNA [NM_023138] KLA .96 1.01 1.09 .99 1.11 1.15 1.42
ATP 1.07 1.05 .74 .86 1.04 1.16 1.21
KLA/ATP 1.14 1.03 .68 .78 .85 1.01 1.20
Map2k5
KLA  ATP  ATP+KLA
 NM_011840 mitogen-activated protein kinase kinase 5 (Map2k5), mRNA [NM_011840] KLA .80 .86 .78 .68 .75 .86 1.09
ATP .97 .90 .71 .85 .81 .98 .80
KLA/ATP .83 .73 .50 .56 .63 .98 .79
Map3k2
KLA  ATP  ATP+KLA
 NM_011946 mitogen-activated protein kinase kinase kinase 2 (Map3k2), mRNA [NM_011946] KLA .80 .79 .74 .79 .93 1.00 1.09
ATP .99 .97 1.05 1.13 1.79 1.27 1.14
KLA/ATP .81 .76 .77 .84 1.39 1.29 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk7
KLA  ATP  ATP+KLA
 NM_011841 mitogen-activated protein kinase 7 (Mapk7), mRNA [NM_011841] KLA .46 .43 .53 .80 1.03 1.38 1.55
ATP .96 .80 .84 .62 1.76 2.01 1.67
KLA/ATP .39 .40 .47 .50 2.55 1.93 2.48
Mm.32574
6
KLA  ATP  ATP+KLA
 118130017 Unknown KLA .71 .67 .65 .62 .73 .74 .83
ATP 1.03 .83 .89 .79 .93 1.17 .78
KLA/ATP .77 .62 .61 .55 .79 1.11 .78
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Mm.47066
1
KLA  ATP  ATP+KLA
 111186463 Unknown KLA .51 .50 .47 .50 .45 .54 .62
ATP 1.07 .92 .91 .65 .66 .43 .29
KLA/ATP .52 .41 .51 .38 .40 .34 .18
Mm.47212
1
KLA  ATP  ATP+KLA
 142378376 Unknown KLA .63 .70 .63 .67 .54 .48 .49
ATP .89 1.10 1.23 1.18 2.76 3.35 .36
KLA/ATP .69 .84 .94 .91 2.11 2.31 .25
Mm.54161
KLA  ATP  ATP+KLA
 164607143 Unknown KLA .97 .99 1.00 .98 .95 .98 .94
ATP 1.01 .99 1.06 1.07 1.02 .95 .98
KLA/ATP .93 1.04 1.07 .96 .90 .95 .94
Nras
KLA  ATP  ATP+KLA
 NM_010937 neuroblastoma ras oncogene (Nras), mRNA [NM_010937] KLA 1.20 1.22 1.27 1.20 1.09 .91 .84
ATP .98 .91 .69 .61 .59 .67 .78
KLA/ATP 1.22 1.14 .97 .79 .73 .61 .72
Pdgfa
KLA  ATP  ATP+KLA
 NM_008808 platelet derived growth factor, alpha (Pdgfa), mRNA [NM_008808] KLA .63 .56 .42 .34 .31 .33 .52
ATP .89 .80 .69 1.23 5.97 3.99 2.73
KLA/ATP .64 .53 .43 .77 3.48 3.78 2.37
Pdgfb
KLA  ATP  ATP+KLA
 NM_011057 platelet derived growth factor, B polypeptide (Pdgfb), mRNA [NM_011057] KLA .45 .43 .38 .46 .69 .48 .58
ATP .94 .95 .66 .74 .67 .77 1.06
KLA/ATP .43 .43 .37 .39 .52 .55 1.64
Pdgfc
KLA  ATP  ATP+KLA
 AK081347 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130008P20 product:platelet-derived growth factor, C polypeptide, full insert sequence. [AK081347] KLA .93 1.07 1.00 1.03 .93 .95 .98
ATP 1.05 1.04 .94 1.02 1.04 1.00 1.05
KLA/ATP 1.06 1.02 .99 .96 .99 1.05 1.01
Pdgfc
KLA  ATP  ATP+KLA
 NM_019971 platelet-derived growth factor, C polypeptide (Pdgfc), mRNA [NM_019971] KLA 1.56 1.52 1.84 2.08 1.83 1.33 .79
ATP .98 .91 .86 .91 .78 1.43 3.28
KLA/ATP 1.45 1.50 1.25 1.73 1.99 1.56 1.12
Pdgfd
KLA  ATP  ATP+KLA
 AK141551 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630020I23 product:platelet-derived growth factor, D polypeptide, full insert sequence [AK141551] KLA 1.07 1.01 1.06 .98 .94 1.00 1.00
ATP .98 .99 1.10 1.00 .96 1.00 .94
KLA/ATP 1.00 1.03 1.05 1.02 .94 .97 1.03
Pdgfd
KLA  ATP  ATP+KLA
 NM_027924 platelet-derived growth factor, D polypeptide (Pdgfd), mRNA [NM_027924] KLA .99 .93 .95 .97 1.00 .99 .95
ATP 1.01 .99 1.00 .93 1.05 1.04 1.06
KLA/ATP .91 .91 .96 .92 .92 .99 1.05
Pdgfra
KLA  ATP  ATP+KLA
 NM_011058 platelet derived growth factor receptor, alpha polypeptide (Pdgfra), transcript variant 1, mRNA [NM_011058] KLA 1.02 1.05 1.02 1.01 1.03 1.03 1.01
ATP 1.01 1.02 1.03 1.04 1.00 1.01 1.01
KLA/ATP 1.01 1.01 .99 1.03 1.02 1.03 1.01
Pdgfrb
KLA  ATP  ATP+KLA
 NM_008809 platelet derived growth factor receptor, beta polypeptide (Pdgfrb), mRNA [NM_008809] KLA 4.85 5.49 4.56 3.94 3.71 2.05 1.51
ATP .99 1.00 1.11 1.27 1.02 1.83 1.23
KLA/ATP 5.09 5.86 4.30 2.51 1.74 1.84 3.23
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkg1
KLA  ATP  ATP+KLA
 NM_011160 protein kinase, cGMP-dependent, type I (Prkg1), transcript variant 2, mRNA [NM_011160] KLA .97 .96 .97 1.08 1.11 .93 .94
ATP 1.07 .96 .94 .99 1.03 1.60 .90
KLA/ATP .95 1.07 1.00 1.04 1.00 1.04 .91
Prkg2
KLA  ATP  ATP+KLA
 NM_008926 protein kinase, cGMP-dependent, type II (Prkg2), mRNA [NM_008926] KLA .97 1.03 1.03 1.02 1.15 .99 .98
ATP 1.02 1.08 .98 .98 1.00 1.00 1.02
KLA/ATP 1.01 1.02 1.03 .97 1.00 .93 1.02
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
Sos1
KLA  ATP  ATP+KLA
 NM_009231 Son of sevenless homolog 1 (Drosophila) (Sos1), mRNA [NM_009231] KLA 2.36 2.40 3.42 3.15 2.78 1.81 1.71
ATP .99 1.00 .99 1.15 1.14 1.25 1.24
KLA/ATP 2.41 2.26 1.95 2.44 1.47 1.66 1.37
Sos2
KLA  ATP  ATP+KLA
 XM_127051 gb|PREDICTED: Mus musculus Son of sevenless homolog 2 (Drosophila) (Sos2), mRNA [XM_127051] KLA .81 .77 .79 .92 1.04 1.06 1.20
ATP 1.00 1.00 1.09 .79 .68 .81 .94
KLA/ATP .77 .69 .71 .60 .64 .77 1.07
Src
KLA  ATP  ATP+KLA
 NM_009271 Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] KLA 6.99 7.23 7.54 5.99 5.34 3.39 3.00
ATP 1.02 1.06 1.06 2.08 4.41 5.03 3.97
KLA/ATP 7.44 7.51 5.48 6.24 4.86 5.86 7.90
Tjp1
KLA  ATP  ATP+KLA
 NM_009386 tight junction protein 1 (Tjp1), mRNA [NM_009386] KLA 1.00 1.03 1.07 1.00 1.03 1.03 1.09
ATP 1.01 .98 1.06 1.00 1.00 1.05 1.04
KLA/ATP .99 1.04 1.06 1.08 1.10 1.21 1.11
Tuba1a
KLA  ATP  ATP+KLA
 NM_011653 tubulin, alpha 1A (Tuba1a), mRNA [NM_011653] KLA .47 .44 .41 .41 .42 .35 .53
ATP 1.01 .94 1.07 .93 .53 .70 .60
KLA/ATP .45 .40 .44 .38 .48 .55 .49
Tuba1c
KLA  ATP  ATP+KLA
 NM_009448 tubulin, alpha 1C (Tuba1c), mRNA [NM_009448] KLA .52 .54 .48 .42 .48 .71 .86
ATP .95 .96 .96 1.01 1.00 .92 .68
KLA/ATP .56 .48 .45 .49 .49 .70 .59
Tuba3a
KLA  ATP  ATP+KLA
 NM_009446 tubulin, alpha 3A (Tuba3a), mRNA [NM_009446] KLA .80 .74 .76 .74 .76 .82 .89
ATP 1.05 1.10 .89 1.18 1.06 .93 .82
KLA/ATP .77 .74 .78 .82 .74 .82 .78
Tuba4a
KLA  ATP  ATP+KLA
 NM_009447 tubulin, alpha 4A (Tuba4a), mRNA [NM_009447] KLA .54 .53 .48 .41 .42 .48 .94
ATP 1.00 1.11 .94 1.27 2.28 2.35 1.12
KLA/ATP .55 .53 .48 .64 1.25 1.79 1.11
Tuba8
KLA  ATP  ATP+KLA
 NM_017379 tubulin, alpha 8 (Tuba8), mRNA [NM_017379] KLA 1.01 1.13 1.19 1.11 1.11 1.20 .98
ATP .92 .99 1.09 1.02 1.01 .96 1.24
KLA/ATP 1.13 1.06 .97 1.13 1.05 1.07 1.11
Tubb2a
KLA  ATP  ATP+KLA
 NM_009450 tubulin, beta 2a (Tubb2a), mRNA [NM_009450] KLA .48 .49 .49 .49 .65 .96 1.04
ATP .95 .98 .88 .91 1.09 1.09 .71
KLA/ATP .52 .50 .46 .53 .89 1.05 .65
Tubb2b
KLA  ATP  ATP+KLA
 NM_023716 tubulin, beta 2b (Tubb2b), mRNA [NM_023716] KLA .67 .70 .68 .78 .57 .55 .53
ATP .91 1.02 1.40 1.30 2.56 3.08 .44
KLA/ATP .73 .84 1.13 .98 2.03 2.04 .36
Tubb2c
KLA  ATP  ATP+KLA
 NM_146116 tubulin, beta 2c (Tubb2c), mRNA [NM_146116] KLA .43 .42 .43 .44 .64 .83 .98
ATP 1.00 1.07 .97 1.24 1.13 1.44 .95
KLA/ATP .48 .44 .44 .75 .71 1.13 .94
Tubb3
KLA  ATP  ATP+KLA
 NM_023279 tubulin, beta 3 (Tubb3), mRNA [NM_023279] KLA 1.56 1.62 1.56 2.14 2.06 2.94 1.61
ATP 1.01 .95 1.36 1.32 1.31 .92 .93
KLA/ATP 1.52 1.66 2.61 2.01 2.11 1.50 1.19
Tubb4
KLA  ATP  ATP+KLA
 NM_009451 tubulin, beta 4 (Tubb4), mRNA [NM_009451] KLA .64 .68 .65 .57 .63 .74 .92
ATP 1.06 1.19 1.02 1.25 .99 .67 .50
KLA/ATP .72 .65 .56 .74 .66 .61 .36
Tubb5
KLA  ATP  ATP+KLA
 NM_011655 tubulin, beta 5 (Tubb5), mRNA [NM_011655] KLA .52 .52 .51 .45 .52 .71 .97
ATP .99 1.02 .91 .91 .72 .55 .48
KLA/ATP .56 .50 .47 .47 .50 .45 .29
Tubb6
KLA  ATP  ATP+KLA
 AK041002 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530059D09 product:unclassifiable, full insert sequence [AK041002] KLA .49 .45 .48 .50 .46 .48 .53
ATP .89 .86 .90 .64 .49 .46 .47
KLA/ATP .42 .42 .57 .55 .48 .39 .38
Tubb6
KLA  ATP  ATP+KLA
 NM_026473 tubulin, beta 6 (Tubb6), mRNA [NM_026473] KLA .87 .85 .83 1.01 1.16 1.44 .34
ATP .90 .91 1.04 1.07 1.78 2.19 1.13
KLA/ATP .83 .75 .90 1.06 1.72 2.38 .91